Hisamitsu Pharmaceutical Inc (4530)

Tokyo
Currency in JPY
3,918.0
-18.0(-0.46%)
Closed·
4530 Scorecard
Full Analysis
Management has been aggressively buying back shares
4530 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,887.03,935.0
52 wk Range
3,709.04,735.0
Key Statistics
Edit
Bid/Ask
3,911.00 / 3,920.00
Prev. Close
3,936
Open
3,925
Day's Range
3,887-3,935
52 wk Range
3,709-4,735
Volume
283.5K
Average Volume (3m)
153.67K
1-Year Change
-1.19%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4530 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4,850.0
Upside
+23.79%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Hisamitsu Pharmaceutical Inc Company Profile

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.

Employees
2799
Market
Japan

Compare 4530 to Peers and Sector

Metrics to compare
4530
Peers
Sector
Relationship
P/E Ratio
14.3x13.6x−0.5x
PEG Ratio
0.370.070.00
Price/Book
1.0x1.0x2.6x
Price / LTM Sales
1.8x1.3x3.2x
Upside (Analyst Target)
23.8%18.4%45.9%
Fair Value Upside
Unlock18.4%7.0%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 4,850.0
(+23.79% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 267.14%
Dividend Yield
2.67%
Industry Median 2.32%
Annualised payout
105.00
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 10, 2025
EPS / Forecast
35.14 / 38.50
Revenue / Forecast
34.67B / 37.50B
EPS Revisions
Last 90 days

4530 Income Statement

FAQ

What Stock Exchange Does Hisamitsu Pharmaceutical Inc Trade On?

Hisamitsu Pharmaceutical Inc is listed and trades on the Tokyo Stock Exchange stock exchange.

What Is the Stock Symbol for Hisamitsu Pharmaceutical Inc?

The stock symbol for Hisamitsu Pharmaceutical Inc is "4530."

What Is the Hisamitsu Pharmaceutical Inc Market Cap?

As of today, Hisamitsu Pharmaceutical Inc market cap is 278.87B.

What Is Hisamitsu Pharmaceutical Inc's Earnings Per Share (TTM)?

The Hisamitsu Pharmaceutical Inc EPS (TTM) is 267.14.

When Is the Next Hisamitsu Pharmaceutical Inc Earnings Date?

Hisamitsu Pharmaceutical Inc will release its next earnings report on 08 Oct 2025.

From a Technical Analysis Perspective, Is 4530 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Hisamitsu Pharmaceutical Inc Stock Split?

Hisamitsu Pharmaceutical Inc has split 1 times.

How Many Employees Does Hisamitsu Pharmaceutical Inc Have?

Hisamitsu Pharmaceutical Inc has 2799 employees.

What is the current trading status of Hisamitsu Pharmaceutical Inc (4530)?

As of 14 Jul 2025, Hisamitsu Pharmaceutical Inc (4530) is trading at a price of 3,918.00, with a previous close of 3,936.00. The stock has fluctuated within a day range of 3,887.00 to 3,935.00, while its 52-week range spans from 3,709.00 to 4,735.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.